Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase III study comparing OSHO arm to standard therapy in adult AML patients <60 years
DRKS00003225Phase 3Recruiting
- Sponsor
- Universitätsklinikum Leipzig
- Start
- Aug 2011
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised trial in acute myeloid leukemia (AML) comparing Cytarabine + Mitoxantrone with Fludarabine + Cytarabine + Mitoxantrone + G-CSF (OSHO arm) (2 arms). Started Aug 2011; status: recruiting.
02
Drugs
cytarabinemitoxantronefludarabinefilgrastim
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on DRKS00003225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003225.